| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |